Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrew Jack.
BMJ | 2008
Andrew Jack
With patents running out on their big earning products and recent scandals undermining their image, drug companies are under pressure. Andrew Jack reports on their problems
BMJ | 2011
Andrew Jack
Drug companies are increasingly obliged to publish details of payments to doctors. The United States is leading the charge, but are we getting the full story in Europe? Andrew Jack reports
BMJ | 2014
Andrew Jack
The government has extended the Cancer Drugs Fund for a further two years and increased its budget. Andrew Jack explains how it works and why it is controversial
BMJ | 2015
Andrew Jack
Andrew Jack reports from Seoul on how government secrecy, poor infection control, and a lack of preparedness allowed the latest MERS outbreak to spark panic in South Korea
BMJ | 2014
Andrew Jack
Is the story of oseltamivir, and similar antiviral drugs, a classic one of big pharma greed? Andrew Jack finds a more nuanced reality
BMJ | 2009
Andrew Jack
With over 96 countries stockpiling oseltamivir, Andrew Jack assesses who has benefited from pandemic flu
BMJ | 2015
Andrew Jack
Pfizer’s actions over its biggest blockbuster drug sparks confusion
BMJ | 2009
Andrew Jack
With the number of cases of swine flu continuing to rise, Andrew Jack assesses our capability to produce enough vaccine to cope with a pandemic
BMJ | 2016
Andrew Jack; firstFT
Demand for and supply of unlicensed drugs online continues to grow despite regulators’ constant attempts to crack down on illegal activity, Andrew Jack reports
BMJ | 2014
Andrew Jack
Pfizer, the US pharmaceutical giant whose drugs include atorvastatin (Lipitor) and sildenafil (Viagra), is seeking to buy the UK drug firm AstraZeneca for £52bn (€63bn;